Suscribirse

A preliminary study on surgery for hepatocellular carcinoma patients with portal hypertension - 12/06/15

Doi : 10.1016/j.amjsurg.2014.08.022 
Yun-Fei Duan, M.D. a, 1, Xiao-Dong Li, M.D. b, 1, Dong-Lin Sun, M.D. a, Xue-Min Chen, M.D. a, Yong An, M.D. a, Feng Zhu, M.D. a,
a Department of Hepatobiliary Surgery, The Third Affiliated Hospital of Soochow University, 185 Juqian Street, Changzhou, Jiangsu Province, China 
b Department of Oncology, The Third Affiliated Hospital of Soochow University, 185 Juqian Street, Changzhou, Jiangsu Province, China 

Corresponding author. Tel./fax: +86-519-68871347.

Abstract

Background

To assess the effects of various operations for hepatocellular carcinoma with portal hypertension (PH).

Methods

Data regarding 78 patients with resectable liver cancer with PH were analyzed. Patients were divided into 3 groups: A (splenic artery ligation), B (in situ splenectomy), and C (in situ splenectomy + pericardial devascularization).

Results

White blood cell and platelet counts in the 3 groups increased significantly after surgery. Postoperative portal pressure was not significantly lower than preoperative portal pressure in Group A, while it was significantly lower in B. In Group C, the portal pressure after splenectomy was significantly lower than that before the operation, but not again after pericardial devascularization. The 1-, 2-, and 3-year survival rates of all the patients were 89.7%, 64.1%, and 46.1%, respectively.

Conclusions

PH is not an absolute contraindication to liver resection in Child–Pugh class B cirrhotic patients. The combined surgery for hepatocellular carcinoma patients with PH is a safe choice.

El texto completo de este artículo está disponible en PDF.

Highlights

This study aimed to assess the effects of various operations for HCC with PH. Data regarding 78 patients with resectable liver cancer with PH were analyzed. Patients were divided into 3 groups: A (splenic artery ligation), B (in situ splenectomy), and C (in situ splenectomy + pericardial devascularization). WBC and platelet counts in 3 groups increased significantly after surgery. Postoperative portal pressure was not significantly lower than preoperative portal pressure in Group A, while it was significantly lower in B. In Group C, the portal pressure after splenectomy was significantly lower than that before the operation, but not again after pericardial devascularization. The 1-, 2-, and 3-year survival rates of all the patients were 89.7%, 64.1%, and 46.1%, respectively. It was concluded that PH is not an absolute contraindication to liver resection in Child–Pugh class B cirrhotic patients. The combined surgery for HCC patients with PH is a safe choice.

El texto completo de este artículo está disponible en PDF.

Keywords : Hepatocellular carcinoma, Cirrhosis, Portal hypertension, Surgery


Esquema


 Supported by funds from the 2013 Applied Basic Research of Changzhou Bureau of Science and Technology provided by Y.-F.D. and Jiangsu Health International Exchange Supporting Program provided by X.-D.L.
 The authors declare no conflicts of interest.


© 2015  Elsevier Inc. Reservados todos los derechos.
Añadir a mi biblioteca Eliminar de mi biblioteca Imprimir
Exportación

    Exportación citas

  • Fichero

  • Contenido

Vol 210 - N° 1

P. 129-133 - juillet 2015 Regresar al número
Artículo precedente Artículo precedente
  • Low 24-hour urine calcium levels in patients with sporadic primary hyperparathyroidism: is further evaluation warranted prior to parathyroidectomy?
  • Kathleen O'Connell, Tina W. Yen, Joseph Shaker, Stuart D. Wilson, Douglas B. Evans, Tracy S. Wang
| Artículo siguiente Artículo siguiente
  • Patient variables impacting hospital costs from 2008 to 2010
  • Brett Aplin, Munier Nazzal, Weikai Qu, Gerald Zelenock, Viviane Kazan, Jihad Abbas

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.

¿Ya suscrito a @@106933@@ revista ?

@@150455@@ Voir plus

Mi cuenta


Declaración CNIL

EM-CONSULTE.COM se declara a la CNIL, la declaración N º 1286925.

En virtud de la Ley N º 78-17 del 6 de enero de 1978, relativa a las computadoras, archivos y libertades, usted tiene el derecho de oposición (art.26 de la ley), el acceso (art.34 a 38 Ley), y correcta (artículo 36 de la ley) los datos que le conciernen. Por lo tanto, usted puede pedir que se corrija, complementado, clarificado, actualizado o suprimido información sobre usted que son inexactos, incompletos, engañosos, obsoletos o cuya recogida o de conservación o uso está prohibido.
La información personal sobre los visitantes de nuestro sitio, incluyendo su identidad, son confidenciales.
El jefe del sitio en el honor se compromete a respetar la confidencialidad de los requisitos legales aplicables en Francia y no de revelar dicha información a terceros.


Todo el contenido en este sitio: Copyright © 2026 Elsevier, sus licenciantes y colaboradores. Se reservan todos los derechos, incluidos los de minería de texto y datos, entrenamiento de IA y tecnologías similares. Para todo el contenido de acceso abierto, se aplican los términos de licencia de Creative Commons.